aluates Reports

$ 0.0

Automative

Global Novel Oral Anticoagulants Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-33M9635

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Novel Oral Anticoagulants Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-33M9635

Report

December 2024

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Bayer

Pfizer Inc

Johnson & Johnson

Boehringer Ingelheim

Daiichi Sankyo

Novel Oral Anticoagulants Drugs Market Size

The global Novel Oral Anticoagulants Drugs market is projected to grow from US$ 23560 million in 2024 to US$ 42200 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.

Novel Oral Anticoagulants Drugs Market

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

Market Analysis and Insights: Global Novel Oral Anticoagulants Drugs Market

The antithrombotic treatment market is driven by the increasing prevalence of cardiovascular diseases and the rising aging population, which are significant risk factors for thrombotic disorders. Antithrombotic therapies, including antiplatelet and anticoagulant drugs, play a crucial role in preventing and treating thrombotic events, such as heart attacks and strokes. The growing adoption of these treatments for various thrombotic indications, along with advancements in drug development and personalized medicine, further propel market growth. However, challenges include balancing the risk of bleeding complications with the benefits of preventing thrombotic events, ensuring optimal dosing and adherence to treatment regimens, and addressing the cost burden of long-term therapy. Overcoming these challenges through continuous research, improved patient education, and collaboration between healthcare providers and pharmaceutical companies will be crucial for the sustained growth of the antithrombotic treatment market.

Report Covers:

This report presents an overview of global market for Novel Oral Anticoagulants Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Novel Oral Anticoagulants Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Novel Oral Anticoagulants Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Novel Oral Anticoagulants Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Novel Oral Anticoagulants Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Novel Oral Anticoagulants Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Novel Oral Anticoagulants Drugs Market Report

Report Metric	Details
Report Name	Novel Oral Anticoagulants Drugs Market
Accounted market size in 2024	US$ 23560 million
Forecasted market size in 2030	US$ 42200 million
CAGR	10.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Direct Thrombin Inhibitor Factor Xa Inhibitors
Segment by Application	Hospital Drugs Stores Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Boehringer Ingelheim, Daiichi Sankyo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Novel Oral Anticoagulants Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Novel Oral Anticoagulants Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Novel Oral Anticoagulants Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Novel Oral Anticoagulants Drugs Market growing?

Ans: The Novel Oral Anticoagulants Drugs Market witnessing a CAGR of 10.2 during the forecast period 2025-2030.

What is the Novel Oral Anticoagulants Drugs Market size in 2030?

Ans: The Novel Oral Anticoagulants Drugs Market size in 2030 will be US$ 42200 million.

Who are the main players in the Novel Oral Anticoagulants Drugs Market report?

Ans: The main players in the Novel Oral Anticoagulants Drugs Market are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Boehringer Ingelheim, Daiichi Sankyo

What are the Application segmentation covered in the Novel Oral Anticoagulants Drugs Market report?

Ans: The Applications covered in the Novel Oral Anticoagulants Drugs Market report are Hospital, Drugs Stores, Other

What are the Type segmentation covered in the Novel Oral Anticoagulants Drugs Market report?

Ans: The Types covered in the Novel Oral Anticoagulants Drugs Market report are Direct Thrombin Inhibitor, Factor Xa Inhibitors

Recommended Reports

Anticoagulants & Antithrombotics

Oral Drug Markets

Thrombosis & Stroke Care

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Direct Thrombin Inhibitor

1.2.3 Factor Xa Inhibitors

1.3 Market by Application

1.3.1 Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drugs Stores

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Novel Oral Anticoagulants Drugs Market Perspective (2019-2030)

2.2 Global Novel Oral Anticoagulants Drugs Growth Trends by Region

2.2.1 Novel Oral Anticoagulants Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Novel Oral Anticoagulants Drugs Historic Market Size by Region (2019-2024)

2.2.3 Novel Oral Anticoagulants Drugs Forecasted Market Size by Region (2025-2030)

2.3 Novel Oral Anticoagulants Drugs Market Dynamics

2.3.1 Novel Oral Anticoagulants Drugs Industry Trends

2.3.2 Novel Oral Anticoagulants Drugs Market Drivers

2.3.3 Novel Oral Anticoagulants Drugs Market Challenges

2.3.4 Novel Oral Anticoagulants Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Novel Oral Anticoagulants Drugs by Players

3.1.1 Global Novel Oral Anticoagulants Drugs Revenue by Players (2019-2024)

3.1.2 Global Novel Oral Anticoagulants Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Novel Oral Anticoagulants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Novel Oral Anticoagulants Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Novel Oral Anticoagulants Drugs Market Concentration Ratio

3.4.1 Global Novel Oral Anticoagulants Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Novel Oral Anticoagulants Drugs Revenue in 2023

3.5 Global Key Players of Novel Oral Anticoagulants Drugs Head office and Area Served

3.6 Global Key Players of Novel Oral Anticoagulants Drugs, Product and Application

3.7 Global Key Players of Novel Oral Anticoagulants Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Novel Oral Anticoagulants Drugs Breakdown Data by Type

4.1 Global Novel Oral Anticoagulants Drugs Historic Market Size by Type (2019-2024)

4.2 Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Type (2025-2030)

5 Novel Oral Anticoagulants Drugs Breakdown Data by Application

5.1 Global Novel Oral Anticoagulants Drugs Historic Market Size by Application (2019-2024)

5.2 Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Novel Oral Anticoagulants Drugs Market Size (2019-2030)

6.2 North America Novel Oral Anticoagulants Drugs Market Size by Type

6.2.1 North America Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024)

6.2.2 North America Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030)

6.2.3 North America Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

6.3 North America Novel Oral Anticoagulants Drugs Market Size by Application

6.3.1 North America Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024)

6.3.2 North America Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030)

6.3.3 North America Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

6.4 North America Novel Oral Anticoagulants Drugs Market Size by Country

6.4.1 North America Novel Oral Anticoagulants Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)

6.4.3 North America Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Novel Oral Anticoagulants Drugs Market Size (2019-2030)

7.2 Europe Novel Oral Anticoagulants Drugs Market Size by Type

7.2.1 Europe Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024)

7.2.2 Europe Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030)

7.2.3 Europe Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

7.3 Europe Novel Oral Anticoagulants Drugs Market Size by Application

7.3.1 Europe Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024)

7.3.2 Europe Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030)

7.3.3 Europe Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

7.4 Europe Novel Oral Anticoagulants Drugs Market Size by Country

7.4.1 Europe Novel Oral Anticoagulants Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)

7.4.3 Europe Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Novel Oral Anticoagulants Drugs Market Size (2019-2030)

8.2 China Novel Oral Anticoagulants Drugs Market Size by Type

8.2.1 China Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024)

8.2.2 China Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030)

8.2.3 China Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

8.3 China Novel Oral Anticoagulants Drugs Market Size by Application

8.3.1 China Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024)

8.3.2 China Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030)

8.3.3 China Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Novel Oral Anticoagulants Drugs Market Size (2019-2030)

9.2 Asia Novel Oral Anticoagulants Drugs Market Size by Type

9.2.1 Asia Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024)

9.2.2 Asia Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030)

9.2.3 Asia Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

9.3 Asia Novel Oral Anticoagulants Drugs Market Size by Application

9.3.1 Asia Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024)

9.3.2 Asia Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030)

9.3.3 Asia Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

9.4 Asia Novel Oral Anticoagulants Drugs Market Size by Region

9.4.1 Asia Novel Oral Anticoagulants Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Novel Oral Anticoagulants Drugs Market Size by Region (2019-2024)

9.4.3 Asia Novel Oral Anticoagulants Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Details

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Introduction

11.1.4 Bristol-Myers Squibb Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)

11.1.5 Bristol-Myers Squibb Recent Developments

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Novel Oral Anticoagulants Drugs Introduction

11.2.4 Bayer Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)

11.2.5 Bayer Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Novel Oral Anticoagulants Drugs Introduction

11.3.4 Pfizer Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)

11.3.5 Pfizer Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Novel Oral Anticoagulants Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)

11.4.5 Johnson & Johnson Recent Developments

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Introduction

11.5.4 Boehringer Ingelheim Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)

11.5.5 Boehringer Ingelheim Recent Developments

11.6 Daiichi Sankyo

11.6.1 Daiichi Sankyo Company Details

11.6.2 Daiichi Sankyo Business Overview

11.6.3 Daiichi Sankyo Novel Oral Anticoagulants Drugs Introduction

11.6.4 Daiichi Sankyo Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024)

11.6.5 Daiichi Sankyo Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol–Myers Squibb

Bayer

Pfizer Inc

Johnson & Johnson

Boehringer Ingelheim

Daiichi Sankyo

List of Tables

Table 1. Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Direct Thrombin Inhibitor

Table 3. Key Players of Factor Xa Inhibitors

Table 4. Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Novel Oral Anticoagulants Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Novel Oral Anticoagulants Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Novel Oral Anticoagulants Drugs Market Share by Region (2019-2024)

Table 8. Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Novel Oral Anticoagulants Drugs Market Share by Region (2025-2030)

Table 10. Novel Oral Anticoagulants Drugs Market Trends

Table 11. Novel Oral Anticoagulants Drugs Market Drivers

Table 12. Novel Oral Anticoagulants Drugs Market Challenges

Table 13. Novel Oral Anticoagulants Drugs Market Restraints

Table 14. Global Novel Oral Anticoagulants Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Novel Oral Anticoagulants Drugs Revenue Share by Players (2019-2024)

Table 16. Global Top Novel Oral Anticoagulants Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Oral Anticoagulants Drugs as of 2023)

Table 17. Global Novel Oral Anticoagulants Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Novel Oral Anticoagulants Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Novel Oral Anticoagulants Drugs, Headquarters and Area Served

Table 20. Global Key Players of Novel Oral Anticoagulants Drugs, Product and Application

Table 21. Global Key Players of Novel Oral Anticoagulants Drugs, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Novel Oral Anticoagulants Drugs Revenue Share by Application (2019-2024)

Table 29. Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Novel Oral Anticoagulants Drugs Revenue Share by Application (2025-2030)

Table 31. North America Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Novel Oral Anticoagulants Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Novel Oral Anticoagulants Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Novel Oral Anticoagulants Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Novel Oral Anticoagulants Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Novel Oral Anticoagulants Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 63. Bristol-Myers Squibb Company Details

Table 64. Bristol-Myers Squibb Business Overview

Table 65. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product

Table 66. Bristol-Myers Squibb Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024) & (US$ Million)

Table 67. Bristol-Myers Squibb Recent Developments

Table 68. Bayer Company Details

Table 69. Bayer Business Overview

Table 70. Bayer Novel Oral Anticoagulants Drugs Product

Table 71. Bayer Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024) & (US$ Million)

Table 72. Bayer Recent Developments

Table 73. Pfizer Company Details

Table 74. Pfizer Business Overview

Table 75. Pfizer Novel Oral Anticoagulants Drugs Product

Table 76. Pfizer Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024) & (US$ Million)

Table 77. Pfizer Recent Developments

Table 78. Johnson & Johnson Company Details

Table 79. Johnson & Johnson Business Overview

Table 80. Johnson & Johnson Novel Oral Anticoagulants Drugs Product

Table 81. Johnson & Johnson Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024) & (US$ Million)

Table 82. Johnson & Johnson Recent Developments

Table 83. Boehringer Ingelheim Company Details

Table 84. Boehringer Ingelheim Business Overview

Table 85. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product

Table 86. Boehringer Ingelheim Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024) & (US$ Million)

Table 87. Boehringer Ingelheim Recent Developments

Table 88. Daiichi Sankyo Company Details

Table 89. Daiichi Sankyo Business Overview

Table 90. Daiichi Sankyo Novel Oral Anticoagulants Drugs Product

Table 91. Daiichi Sankyo Revenue in Novel Oral Anticoagulants Drugs Business (2019-2024) & (US$ Million)

Table 92. Daiichi Sankyo Recent Developments

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Novel Oral Anticoagulants Drugs Market Share by Type: 2023 VS 2030

Figure 3. Direct Thrombin Inhibitor Features

Figure 4. Factor Xa Inhibitors Features

Figure 5. Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Novel Oral Anticoagulants Drugs Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Drugs Stores Case Studies

Figure 9. Other Case Studies

Figure 10. Novel Oral Anticoagulants Drugs Report Years Considered

Figure 11. Global Novel Oral Anticoagulants Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Novel Oral Anticoagulants Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Novel Oral Anticoagulants Drugs Market Share by Region: 2023 VS 2030

Figure 14. Global Novel Oral Anticoagulants Drugs Market Share by Players in 2023

Figure 15. Global Top Novel Oral Anticoagulants Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Oral Anticoagulants Drugs as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Novel Oral Anticoagulants Drugs Revenue in 2023

Figure 17. North America Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

Figure 19. North America Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

Figure 20. North America Novel Oral Anticoagulants Drugs Market Share by Country (2019-2030)

Figure 21. United States Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Novel Oral Anticoagulants Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

Figure 25. Europe Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

Figure 26. Europe Novel Oral Anticoagulants Drugs Market Share by Country (2019-2030)

Figure 27. Germany Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Novel Oral Anticoagulants Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

Figure 35. China Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

Figure 36. Asia Novel Oral Anticoagulants Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

Figure 38. Asia Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

Figure 39. Asia Novel Oral Anticoagulants Drugs Market Share by Region (2019-2030)

Figure 40. Japan Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Novel Oral Anticoagulants Drugs Market Share by Country (2019-2030)

Figure 50. Brazil Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Novel Oral Anticoagulants Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2019-2024)

Figure 57. Bayer Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2019-2024)

Figure 59. Johnson & Johnson Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2019-2024)

Figure 60. Boehringer Ingelheim Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2019-2024)

Figure 61. Daiichi Sankyo Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anticoagulant Treatment Market Insights Forecast to 2030

Global Oral Anticoagulants Market Research Report 2024

Global Direct Oral Anticoagulant Market Insights Forecast to 2030

Global Antithrombotic Treatment Market Insights Forecast to 2030

Global Dabigatran Market Insights Forecast to 2030

Global Anticoagulant Medicines Market Research Report 2025

Global Intravenous Anticoagulants Market Research Report 2024

Anticoagulants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Heparin Anticoagulant Market Insights Forecast to 2028

Global Thrombosis Drug Market Research Report 2025

Global Anticoagulant Medications Market Research Report 2024

Global Rivaroxaban Drugs Market Research Report 2024

Global Injectable Blood Thinners Market Research Report 2025

Global Oral Factor Xa Inhibitors Market Research Report 2024

Global Oral Anticoagulant Reversal Drug Market Research Report 2025

Global Anticoagulant Reversal Agent Market Research Report 2024

Global Heparin Market Insights Forecast to 2030

Global Anticoagulant Medicine Market Research Report 2025

Global Thrombin Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10O16568

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0R20253

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3G16891

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4B16895

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Novel Oral Anticoagulants Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-33M9635

Global Novel Oral Anticoagulants Drugs Market Insights, Forecast to 2030

FEATURED COMPANIES

Novel Oral Anticoagulants Drugs Market Size

Novel Oral Anticoagulants Drugs Market

Scope of Novel Oral Anticoagulants Drugs Market Report

Chapter Outline

FAQ for this report

How fast is Novel Oral Anticoagulants Drugs Market growing?

What is the Novel Oral Anticoagulants Drugs Market size in 2030?

Who are the main players in the Novel Oral Anticoagulants Drugs Market report?

What are the Application segmentation covered in the Novel Oral Anticoagulants Drugs Market report?

What are the Type segmentation covered in the Novel Oral Anticoagulants Drugs Market report?

Recommended Reports

Anticoagulants & Antithrombotics

Oral Drug Markets

Thrombosis & Stroke Care

FEATURED COMPANIES

RELATED REPORTS